Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2009
05/21/2009US20090131655 Cephem Compounds Having Broad Antibacterial Spectrum
05/21/2009US20090131652 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
05/21/2009US20090131539 Mixture
05/21/2009US20090131538 Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
05/21/2009US20090131537 Wound healing compositions
05/21/2009US20090131536 Treating or Preventing Renal Cancer Using a Dimethane Sulfonate
05/21/2009US20090131535 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
05/21/2009US20090131534 Abuse-resistant amphetamine prodrugs
05/21/2009US20090131533 Abuse-resistant amphetamine prodrugs
05/21/2009US20090131532 Method of preemptive treatment of inflammation, algesia and poor healing using topical capsaicin
05/21/2009US20090131530 4- (or 5-) substituted catechol derivatives
05/21/2009US20090131529 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
05/21/2009US20090131528 Salt
05/21/2009US20090131527 Novel anthranilic acid derivatives and chloride channel blocking agent containing the same
05/21/2009US20090131526 Abuse-resistant amphetamine prodrugs
05/21/2009US20090131525 Administering L-lysine-d-amphetamine or salts
05/21/2009US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets
05/21/2009US20090131523 Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis
05/21/2009US20090131522 Skin Cell Activator Extracted From Liver Of Fish Or Shellfish And Hair Growth Agent Using The Same
05/21/2009US20090131521 Aqueous retinoid and benzoyl peroxide gel
05/21/2009US20090131520 Lipid metabolism Improving Composition
05/21/2009US20090131517 Antimicrobial and Antifungal Powders Made by Flame Spray Pyrolysis
05/21/2009US20090131516 for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability
05/21/2009US20090131515 Combination of antidiabetic drugs
05/21/2009US20090131514 Buccal, polar and non-polar sprays containing propofol
05/21/2009US20090131513 Anti-inflammatory modalities
05/21/2009US20090131512 Inhibition of type I in IFN production
05/21/2009US20090131511 Palmarumycin based inhibitors of thioredoxin and methods of using same
05/21/2009US20090131510 Compounds with activity at estrogen receptors
05/21/2009US20090131509 Aminoacid Derivatives Containing a Disulfanyl Group in the form of Mixed Disulfanyl and Aminopeptidase N Inhibitors
05/21/2009US20090131508 Use of 2-Oxo-1-Pyrrolidone Derivatives for the Preparation of a Drug
05/21/2009US20090131507 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases
05/21/2009US20090131506 protein kinase activators or inhibitors such as 3-(Amino-phenyl-methylene)-6-chloro-1,3-dihydro-indol-2-one,used for the treatment of cancer, tumors, atherosclerosis, vision defects, diabetic retinopathy and inflammatory diseases
05/21/2009US20090131505 chronic lymphocytic leukemia or acute lymphoblastic leukemia; use of specific compound (1R)-cyclopropanecarboxylic acid {2-[2-carbamoyl-1-(3-ethoxy-4-methoxy-phenyl)-ethyl]-7-chloro-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
05/21/2009US20090131504 Use of melatonin-containing oral supplement with animals
05/21/2009US20090131503 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
05/21/2009US20090131502 Biologically active compounds
05/21/2009US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages
05/21/2009US20090131500 Porphyrin derivates and their use as photosensitizers in photodynamic therapy
05/21/2009US20090131499 Photodynamic therapy for skin related problems
05/21/2009US20090131498 Enantioselective Synthesis of Merrilactone and Its Analogs
05/21/2009US20090131497 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
05/21/2009US20090131496 Pyrazolone derivative emulsion formulations
05/21/2009US20090131495 Method for the prevention and treatment of essential tremor by regulating alpha1g t-type calcium channel or by t-type calcium channel blockers
05/21/2009US20090131494 Non-Nucleoside Reverse Transcriptase Inhibitors
05/21/2009US20090131493 Substituted benzimidazoles for treatment of histomoniasis
05/21/2009US20090131492 Indole derivatives as CFTR modulators
05/21/2009US20090131491 ISOXAZOLE DERIVATIVE AND ISOTHIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11(beta)-HYDROXYSTEROID DEHYDROGENASE TYPE I
05/21/2009US20090131490 Methods of treating pulmonary disease using acetazolamide and structurally related derivatives
05/21/2009US20090131489 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/21/2009US20090131488 Compositions and methods for treating hyperproliferative epidermal diseases
05/21/2009US20090131487 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors, angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents
05/21/2009US20090131486 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
05/21/2009US20090131485 Deuterated pirfenidone
05/21/2009US20090131484 Preventive or remedy for bowel disease
05/21/2009US20090131483 2-pyridine derivatives as inhibitors of neutrophile elastase
05/21/2009US20090131482 Methyl-benzimidazole derivatives
05/21/2009US20090131481 Transcription Factor Modulating Compounds and Methods of Use Thereof
05/21/2009US20090131480 Dihydropyridine Compounds for Neurodegenerative Diseases and Dementia
05/21/2009US20090131479 Small-volume oral transmucosal dosage
05/21/2009US20090131478 Growth Hormone Secretagogues
05/21/2009US20090131477 New use of iloperidone
05/21/2009US20090131476 Abuse-resistant amphetamine prodrugs
05/21/2009US20090131475 Compositions and methods for the treatment of metabolic disorders
05/21/2009US20090131474 Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered thereby
05/21/2009US20090131473 2-(aryloxy) acetamide factor viia inhibitors useful as anticoagulants
05/21/2009US20090131472 P38 Kinase Inhibiting Agents
05/21/2009US20090131471 Compositions useful for treating gastroesophageal reflux disease
05/21/2009US20090131470 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
05/21/2009US20090131469 Pharmaceutical agent comprising solifenacin
05/21/2009US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065
05/21/2009US20090131467 Heterocycle Compound, and Production Process and Application Thereof
05/21/2009US20090131466 Pharmaceutical Compositions
05/21/2009US20090131465 Synthesis and crystalline forms of melanocortin-4 receptor agonist
05/21/2009US20090131464 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
05/21/2009US20090131463 Novel compounds
05/21/2009US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
05/21/2009US20090131460 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
05/21/2009US20090131459 2-Thioxanthine Derivatives Acting as MPO-Inhibitors
05/21/2009US20090131458 Compounds
05/21/2009US20090131457 Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders
05/21/2009US20090131456 Caspase inhibitors and uses thereof
05/21/2009US20090131455 Heterocyclic derivatives
05/21/2009US20090131454 New compounds 067
05/21/2009US20090131453 Benzylpiperazine derivatives as motilin receptor antagonists
05/21/2009US20090131452 4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methoxy-phenyl]- piperazine-1-carboxylic acid tert-butyl ester; nervous system disorders, particularly the central nervous system; obesity; cogition activators; Alzheimer's disease; drug abuse, drug dependence; schizophrenia; bioavailability; stability
05/21/2009US20090131451 Diagnosis and treatment of type 2 diabetes and other disorders
05/21/2009US20090131450 Use of pkc inhibitors in diabetic complications
05/21/2009US20090131449 Use of trpv1 receptor antagonists for treating dry eye and ocular pain
05/21/2009US20090131448 2-(Piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
05/21/2009US20090131447 Combination therapy
05/21/2009US20090131446 Fused pyrazine compounds useful for the treatment of degenerative and inflmmatory diseases
05/21/2009US20090131445 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
05/21/2009US20090131444 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
05/21/2009US20090131443 Method for prevention and/or treatment of rheumatoid arthritis
05/21/2009US20090131442 Method of Treating Bone Pain Caused by Osteoarthritis
05/21/2009US20090131441 Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them
05/21/2009US20090131440 Heterocyclic derivatives as modulators of ion channels
05/21/2009US20090131439 Therapeutic agent for chronic obstructive pulmonary disease
05/21/2009US20090131438 Triazole derivative
1 ... 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 2745 ... 7860